Data from FDA (Food and Drug Administration, USA) - Curated by EPG Health - Last updated 22 February 2017
PRECAUTIONS General A
The finding of an
Gallium Citrate Ga 67 Injection is intended for use as an adjunct in the diagnosis of certain neoplasms as well as focal areas of
Certain pathologic conditions may yield up to 40 percent
Lymphocytic lymphoma frequently does not accumulate
Gallium Ga-67 localization can not differentiate between tumor and
As in the use of any radioactive material,
It is essential that the user follow
Radiopharmaceuticals should be used only by physicians who are qualified by training and experience in the
Pregnancy Category C Animal reproductive studies have not been conducted with Gallium Citrate Ga 67.
It is also not known whether Gallium Citrate Ga 67 can cause fetal
Gallium Citrate Ga 67 should be given to a pregnant woman only if clearly needed.
Nursing Mothers This drug is known to be excreted in human milk during lactation, therefore, formula feedings should be substituted for breast feedings.
DOSAGE AND ADMINISTRATION The
Gallium Citrate Ga 67 Injection is intended for intravenous administration only.
Approximately 10 percent of the administered dose is excreted in the feces during the first week after injection.
Daily laxatives and/or
Studies indicate the
The patient dose should be measured by a
Parenteral drug products should be inspected visually for particulate matter and
Instructions for the handling of Gallium Citrate Ga 67:
|Date Last Revised||30-10-2015|
|Type||HUMAN PRESCRIPTION DRUG|
|Storage and handling||
Storage and Handling The contents of the vial are radioactive, and
Storage and disposal of Gallium Citrate Ga 67 Injection should be controlled in a manner that is in
Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company.
© 2015 Mallinckrodt.
Manufactured by: Mallinckrodt Nuclear Medicine LLC Maryland Heights, MO 63043 Made in USA A180I0 Rev 10/2015 MallinckrodtTM Pharmaceuticals
|Marketing authorisation holder||MALLINCKRODT NUCLEAR MEDICINE LLC|